The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
No Data Available.
Synonyms :
methamphetamine
Class :
CNS Stimulant agents
Brand Name :
No Data Available.
Synonyms :
methamphetamine
Class :
CNS Stimulant agents
Dosage Forms & Strengths
Tablet, Oral:
5 mg
10 mg
Note: Not preferred as a first therapeutic option for treatment of ADHD, replaced by other agents.
Attention Deficit Hyperactivity Disorder (ADHD)
Initial dose:
5
mg
Orally
once or twice a day (administer in the early morning)
Increase 5 mg at weekly intervals until the required response is achieved (usual effective dose: 20 to 25 mg divided into two doses per day)
Dosage Forms & Strengths
Tablet, Oral:
5 mg
10 mg
Note: Not preferred as a first therapeutic option for treatment of ADHD, replaced by other agents.
Attention Deficit Hyperactivity Disorder (ADHD)
For >6 years: Initial dose:
5
mg
Orally
once or twice a day (administer in the early morning)
Increase 5 mg at weekly intervals until the required response is achieved (usual effective dose: 20 to 25 mg divided into two doses per day)
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
they decrease the effect of analgesia of opioid agonists
they decrease the effect of analgesia of opioid agonists
may increase the hypertensive effect
MAO inhibitors increase the effect of hypertension of amphetamines
MAO inhibitors increase the effect of hypertension of amphetamines
MAO inhibitors increase the effect of hypertension of amphetamines
MAO inhibitors increase the effect of hypertension of amphetamines
MAO inhibitors increase the effect of hypertension of amphetamines
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may have an increased hypertensive effect when combined with amphetamines
Amphetamines may reduce the antihypertensive effect of antihypertensive Agents.
Amphetamines may reduce the antihypertensive effect of antihypertensive Agents.
Amphetamines may reduce the antihypertensive effect of antihypertensive Agents.
Amphetamines may reduce the antihypertensive effect of antihypertensive Agents.
Amphetamines may reduce the antihypertensive effect of antihypertensive Agents.
amphetamines may enhance the cardiotoxic effect of quinolones
amphetamines may enhance the cardiotoxic effect of quinolones
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
antipsychotic agents may enhance the adverse/toxic effect of amphetamines
it decreases the efficacy of antihypertensive agents
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
they increase the effect of analgesia of opioid agonists
they increase the effect of analgesia of opioid agonists
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may enhance the toxic effect of quinolones
may enhance the toxic effect of quinolones
may enhance the effect of SSRI
may enhance the effect of SSRI
may enhance the effect of SSRI
may enhance the effect of SSRI
may enhance the effect of SSRI
may enhance the effect of SSRI's
may enhance the effect of SSRI's
may enhance the effect of SSRI's
may enhance the effect of SSRI's
may enhance the effect of SSRI's
may enhance the effect of Serotonergic Agents
It may diminish the levels when combined with sodium acid phosphate by enhancing renal clearance
may increase the analgesic effect of opioid agonists
may increase the analgesic effect of opioid agonists
may increase the analgesic effect of opioid agonists
may increase the analgesic effect of opioid agonists
they decrease the effect of hypertension of antihypertensive agents
they decrease the effect of hypertension of angiotensin II
they decrease the effect of hypertension of angiotensin II
they decrease the effect of hypertension of angiotensin II
they decrease the effect of hypertension of angiotensin II
they decrease the effect of hypertension of angiotensin II
they decrease the effect of hypertension of angiotensin II
they decrease the effect of hypertension of angiotensin II
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
it may increase the effect of serotonergic agents
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
may enhance the serotonergic effect of serotonergic Agents
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
antacids reduce the excretion of amphetamines
antacids reduce the excretion of amphetamines
antacids reduce the excretion of amphetamines
antacids reduce the excretion of amphetamines
antacids reduce the excretion of amphetamines
antacids may decrease the excretion of amphetamines
antacids may decrease the excretion of amphetamines
antacids may decrease the excretion of amphetamines
antacids may decrease the excretion of amphetamines
antacids may decrease the excretion of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may enhance the adverse/toxic effect of amphetamines
may increase the analgesic effect of opioids
may decrease the hypertensive effect of anti-hypertensive agents
lisinopril/hydrochlorothiazide
may decrease the anti-hypertensive effect of anti-hypertensive agents
may increase the adverse effect of amphetamines
may increase the adverse effect of amphetamines
may increase the adverse effect of amphetamines
may increase the adverse effect of amphetamines
may increase the adverse effect of amphetamines
may increase the toxic effect of antipsychotic agents
may increase the toxic effect of antipsychotics
may reduce the rate of excretion of amphetamines
may reduce the rate of excretion of amphetamines
may reduce the rate of excretion of amphetamines
may reduce the rate of excretion of amphetamines
may reduce the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
May reduce the levels of serum concentration of amphetamines
May reduce the levels of serum concentration of amphetamines
May reduce the levels of serum concentration of amphetamines
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the analgesic effect of Opioid Agonists
may increase the risk of adverse effect of amphetamines
may increase the risk of adverse effect of amphetamines
may increase the risk of adverse effect of amphetamines
may increase the risk of adverse effect of amphetamines
may increase the risk of adverse effect of amphetamines
ciprofloxacin inhaled (Pending FDA approval)
may increase the cardiotoxic effect of Quinolones
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may have an increased analgesic effect when combined with opioid agonists
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
may have an increasingly adverse effect when combined with amphetamines
Frequency defined:
>10%
Headache
Decreased appetite
Abdominal pain
Emotional lability
Allergic rhinitis
Epistaxis
Frequency not defined
Acute myocardial infarction
Cardiomyopathy
Palpitations
Tachycardia
Skin rash
Stevens johnson syndrome
Toxic epidermal necrolysis
Weight loss
Change in libido
Anorexia
Diarrhea
Unpleasant taste
Impotence
Prolonged erection
Aggressive behavior
Depression
Dizziness
Drug abuse
Drug dependence
Dysphoria
euphoria
headache
restlessness
psychosis
overstimulation
talkativeness
Postmarketing
Angioedema
Hepatotoxicity
Delusion
Hallucination
Suicidal ideation
Pregnancy consideration: Studies reported an increased risk of premature birth and low birth weight during pregnancy.
Lactation: Methamphetamine can be excreted in breast milk.
Pregnancy category:
Patient information leaflet
Generic Name: Methamphetamine
Pronounced: methamphetamine
Why do we use methamphetamine?
Methamphetamine is used to treat conditions related to daytime sleepiness. It is used for ADHD.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
